The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Clinic Laboratories news, and upcoming events.
Study Mines Cancer Genetics to Help with Targeted Treatment
Scientists have analyzed the full genetic blueprints of more than 18,000 cancer samples, finding new patterns of mutations that could help doctors provide better, more personalized treatment. Via AP
Some Psychiatric Conditions May Raise Risk of Breakthrough COVID-19, Study Finds
Researchers from the University of California San Francisco and San Francisco Veterans Affairs Health Care System led the study, which involved EHR data from 263,697 VA patients. Via Becker's
Mayo Clinic is partnering with a technology startup to develop a staffing app that will try to prevent nursing burnout by helping match them to specific jobs. A pilot of the app will be launched at Mayo Clinic soon. Via Healthcare IT News
New blood biomarker may lead to early diagnosis of frontotemporal dementia
A collaboration between Mayo Clinic researchers and a team dedicated to researching frontotemporal dementia has identified neurofilament light as a useful biomarker for the disease.
“Through this study, we have created a major informational database comprising cross-sectional and longitudinal [neurofilament light]data, along with demographic, genetic, clinical and neuropsychological data,” Leonard Petrucelli, PhD, a Mayo Clinic neuroscientist and corresponding author on the study, said in the release. Via Healio
Mayo in Mankato unveils new diagnostic imaging department
System leaders marked the grand opening of the health care provider's new diagnostic imaging department Tuesday at Madison East Center. Outpatient diagnostic imaging services were previously mainly provided by Mayo in Mankato's hospital campus. The new diagnostic imaging department represents a $16 million investment in the community, said Dr. James Hebl, regional vice president of Mayo Clinic Health System in southwest Minnesota. Via Yahoo! News
Mayo Clinic AI reduces by twofold precancerous polyp miss rate, study says
"Colorectal cancer is almost entirely preventable with proper screening," said Michael B. Wallace, MD, senior author of the study, division chair of gastroenterology and hepatology at Abu Dhabi, UAE-based Sheikh Shakhbout Medical City and the Fred C. Andersen professor of medicine at Jacksonville, Fla.-based Mayo Clinic. "Using artificial intelligence to detect colon polyps and potentially save lives is welcome and promising news for patients and their families." Via Becker's